The findings of the study revealed an elevation in the bronchial expression of FGF-1, FGF-2, and FGFR-1 in COPD patients, suggesting their potential involvement in regulating pulmonary airway remodeling [77]. Here, FGF2 is linked to chronic obstructive pulmonary disease.